The spread of two strains of Staphylococcus aureus with high level resistance to mupirocin is described. The resistance proved to be easily transferred to other S. aureus strains by filter mating experiments and on the skin of mice. No plasmid band corresponding to the resistance could be demonstrated by agarose gel electrophoresis or by caesium chloride gradient centrifugation but cleavage of ' chromosomal' DNA from resistant recipients showed bright bands of DNA absent from sensitive controls.
INTRODUCTION
Initial clinical studies on a new topical antibiotic, mupirocin (Bactroban, Beecham Pharmaceuticals) were published in 1985 (Dobson et al. 1985) . Mupirocin is a new class of antibiotic which blocks protein synthesis by inhibition of isoleucyl tRNA synthetase. Early studies showed that low level resistance (MIC 12-50 mg/1) could be selected by repeated subculture of staphylococci in the presence of the antibiotic (White et al. 1985) . However, in 1987 we observed and reported (Rahman, Noble & Cookson, 1987) high level mupirocin resistance in Staphylococcus aureus isolated from patients in the dermatology wards at our hospital. Others have also reported high level resistance (Smith & Kennedy, 1988) . This paper reports details of the outbreak of colonization/infection in our wards and the initial studies on transmissibility and nature of the resistance genes.
MATERIALS AND METHODS
There are two wards for dermatology patients (E and B) each consisting of 5 bays of 4-6 beds and 4 single bedded side rooms. Patients admitted to these wards are in the care of several different consultants but shared junior staff.
S. aureus isolates from clinical microbiology specimens were routinely tested for resistance to penicillin (10 i. method on Mueller-Hinton agar at 37 °C and to methicillin (5 /ig) at 30 °C; all disks and media are from Oxoid. Isolates were not tested for resistance to mupirocin unless the request form stated that this antibiotic had been prescribed. When the first mupirocin resistant isolate was recovered, all patients in E ward were screened for carriage of mupirocin-resistant S. aureus in the nose, throat, perineum and any skin lesions using swabs moistened in peptone water. Similar studies were made at weekly intervals until we were convinced that all mupirocin resistant staphylococci had disappeared. Thereafter all S. aureus isolates from patients admitted to the wards have been tested for resistance to mupirocin by inclusion of a 5 fig disk in the routine testing.
The minimal inhibitory concentration of mupirocin was determined by incorporating the antibiotic in blood agar base (Oxoid) and spot-inoculating c. 10 4 cells in broth culture followed by overnight incubation at 37 °C. Phage-typing was carried out at the Institute laboratories using the International set of phages and standard techniques, and also by the Division of Hospital Infection, Central Public Health Laboratory. Plasmid profiling was carried out as described in Dowsett et al. (1984) . Curing of resistance was attempted by growing staphylococci at 42 °C with repeated subculture (Asheshov, 1966) . Resistance transfers on mouse skin and on niters were made as described in Naidoo & Noble (1987) , mixed broth culture studies were made as described by Cookson & Phillips (1988) and attempts to induce phage made using mitomycin C. Centrifugation in caesium chloride/ethidium bromide was carried out using an MSE Europa centrifuge at 50000 rev./min. for 45-65 h. Endonuclease cleavage of density gradient derived DNA was carried out according to the suppliers instructions using Eco RI, Hind III and Bam HI (Gibco Ltd).
RESULTS
When the index case (patient A) was noted on ward E, all patients were screened and a further six carriers in ward E were detected (Fig. 1) . A single positive patient (N) was later revealed on ward B; records showed that two patients B and C had been transferred from ward E to B for Christmas though patient N was not present at this time. No further carriers were detected on ward B but several more became positive on ward E. Swabs from the nose and any skin lesions of staff failed to reveal any carriers of mupirocin-resistant staphylococci and environmental contamination was slight (data not shown).
Clinicians were requested to withdraw mupirocin therapy and heavily colonized patients were nursed in the side rooms. The value of Hibisol (ICI) hand disinfection between patients was emphasised for staff. Application of chlorhexidinecontaining products to patients' skin was generally contra-indicated for fear of exacerbating skin lesions.
A study of prescriptions issued on the ward revealed that five patients (A, B, C, D, N) had been receiving mupirocin for several weeks or months, without our knowledge. In all five cases the antibiotic had been prescribed for use as required and in three patients (B, C, D) this had been intermittent. Other therapies included topical steroids, flucloxacillin and erythromycin.
Retrospective testing of S. aureus isolates available from the weeks immediately prior to the outbreak revealed only one further mupirocin-resistant isolate, a blood culture contaminant from patient B isolated at the same time as the 'index' case. Sixteen isolates of S. aureus which were resistant to penicillin and erythromycin or to penicillin, tetracycline and erythromycin were available from the period October 1986 to February 1987; all were mupirocin sensitive and were of different phage types to the epidemic strains.
The epidemic strains
Mupirocin resistance at MIC > 2000 mg/1 was found in two strains of S. aureus. One strain was also resistant to penicillin and erythromycin and the other to penicillin, erythromycin and tetracycline. Although both were lysed by several phages of group III, the plasmid profiles were so different (Fig. 2) as to suggest that they were wholly independent. In some instances mupirocin sensitive isolates were available which showed the same remaining antibiotic resistance pattern, phage type and plasmid profile as the subsequent mupirocin resistant strains (see Fig. 1 ). Patient C had at one stage carried an epidemic methicillin-resistant S. aureus (EMRSA) (Cookson & Phillips, 1988) . None of the five available isolates of EMRSA from this patient was mupirocin resistant but mupirocin resistance transfer was achieved to this strain (see below).
Prospective studies in the two wards for the 6 months following the end of the epidemic revealed that 989 staphylococcal isolates from 191 colonized patients were reported by the clinical laboratory. Only two isolates were mupirocin resistant and these came from patient B during a routine readmission. 
Laboratory studies
The donor isolates used in laboratory studies are shown in Table 1A . Initial experiments revealed that high level mupirocin resistance was readily lost from strains F4B, B and G under conditions of elevated temperature at which other resistances were also lost ( Table 2) . Electrophoresis of cured isolates showed that loss of erythromycin resistance was associated with loss of a plasmid band at about 2-7 kb and loss of tetracycline resistance with loss of a plasmid band at about 4-2 kb. However, no plasmid band could be associated with loss of mupirocin resistance. This was initially felt to be due partly to the faint OC and linear forms of other plasmids, especially in the Pc R Tc R E m R isolates. Accordingly, mupirocin resistance was transferred into a number of recipient strains (Table IB) known to contain no plasmids or to contain a specific plasmid. The results for transfer frequencies in filter mating are shown in Table 3 . No high level mupirocin resistance was detected when only the recipient strain was inoculated on to selective agar.
Transfer occurred at comparable rates even when 0-02 M sodium citrate was incorporated in the agar on which the filter was incubated (data not shown). Culture supernatants and mitomycin C induction lysates failed to transfer mupirocin resistance (data not shown).
In vivo transfer of mupirocin resistance occurred to recipient 8325 Rif from F4B (2xlO~3) and G (1 x 10~5). These are mean rates for two animals in each instance. Several representative colonies of each successful transfer were checked for the appropriate antibiotic sensitivity and plasmid profile in order to eliminate breakthrough of the donor, an acknowledged problem when rifampicin or fusidic acid are used as selective agents. Transferants were resistant to mupirocin at the same high level as the donors. Mupirocin resistance could also be serially transferred from 8325 to other 8325 derivatives and to 80CR5 as shown in Table 4 . Transferants could also be cured of mupirocin resistance.
Electrophoresis of transferants showed that some possessed a sharp band at about 30 kb (Fig. 3) and it was initially assumed that this represented the ' Mupirocin-resistance plasmid'. Not all transferants possessed this band and a faint band could be seen in 8325 sensitive to mupirocin; when present, the sharp band was brighter if the isolates had first been grown on media containing mupirocin at 20 mg/1. Caesium chloride centrifugation of DNA prepared from eight transferants in 8325 revealed only one band, that corresponding to the chromosomal DNA in control preparations.
Endonuclease cleavage of this density gradient derived, apparently chromosomal, DNA showed that several bright bands could be seen in electrophoretic gels of DNA prepared from resistant transferants. These were superimposed on the faint bands of cleaved chromosomal DNA also seen in the sensitive controls (Fig. 4) . Each enzyme gave different bands and cleavage by two enzymes gave the expected increase in number of bands and decrease in band size indicated by increased mobility in the gel. All transferants gave the same band pattern.
DISCUSSION
The epidemiology of this outbreak has not been fully investigated because we were alerted to the possibility of resistance only after five patients had been receiving intermittent mupirocin therapy for long periods. The presence of high level resistance in two distinct strains of S. aureus in one ward suggested to us that the resistance might be transferable.
Initial results indicated that mupirocin resistance might be located on a conjugative plasmid in the same manner as gentamicin. The rates of transfer were about the same as for gentamicin in our experience (Naidoo & Noble, 1978) and in that of others (McDonnell, Sweeney & Cohen, 1983; Forbes & Schaberg, 1983) and transfer occurred on mouse skin at lower densities of organisms than was the case on filters. It seemed improbable that selection of high level resistance amongst the recipients occurred in the absence of gene-transfer because (a) controls comprising only recipients failed to yield resistant variants, (b) acquisition of resistance occurred only in the presence of certain potential donors (data not shown).
If a plasmid band had been found consistently in all transferants we should have concluded that plasmid transfer, probably conjugative transfer, had occurred. However plasmid bands were not always seen and it is doubtful if the sharp band at c. 30 kb represents conventional closed circular plasmid DNA. Centrifugation in density gradients also failed to reveal CCC plasmid DNA though endonuclease cleavage of this DNA seems to reveal extra-chromosomal DNA associated with the transfer of high level mupirocin resistance. Conjugative plasmids bearing genes for gentamicin resistance are well established in S. aureus and the conjugative transfer of aminoglycoside resistance in the absence of plasmid DNA has been recorded (El Sohl et al. 1986) . Conjugative transposons which might also explain the phenomenon have not yet been reported in S. aureus (Murphy, 1988) though well established in streptococci (Clewell, 1986) . The results reported here seem more likely to reflect a new type of plasmid element, perhaps similar to the open circular plasmids described by Townsend et al. (1986) , co-migrating with the chromosomal DNA in both agarose gels and caesium chloride density gradients, than to be a multicopy transposon which is enriched during preparative procedures designed to demonstrate plasmid DNA.
